Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

COLORMAX COLOR VISION ENHANCEMENT LENSES

K-Number: K984219 · 1999-11-18

ApplicantColor Vision Technologies, Inc.
Decision Date1999-11-18
Product CodeNAI
Advisory CommitteeOP
DecisionSubstantially Equivalent

Device Summary

COLORMAX COLOR VISION ENHANCEMENT LENSES is the device name listed in this FDA 510(k) record. The listed applicant is Color Vision Technologies, Inc.. It received FDA 510(k) clearance on 1999-11-18 under 510(k) number K984219. The device is classified under product code NAI. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the COLORMAX COLOR VISION ENHANCEMENT LENSES?

COLORMAX COLOR VISION ENHANCEMENT LENSES is a medical device that received FDA 510(k) clearance on 1999-11-18. The listed applicant is Color Vision Technologies, Inc.. The 510(k) number is K984219.

When did COLORMAX COLOR VISION ENHANCEMENT LENSES receive FDA 510(k) clearance?

COLORMAX COLOR VISION ENHANCEMENT LENSES received FDA 510(k) clearance on 1999-11-18, under 510(k) number K984219.

Who is the listed applicant for COLORMAX COLOR VISION ENHANCEMENT LENSES?

The FDA 510(k) record lists Color Vision Technologies, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for COLORMAX COLOR VISION ENHANCEMENT LENSES?

The FDA product code for COLORMAX COLOR VISION ENHANCEMENT LENSES is NAI.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑